Remdesivir therapy associated with Bradycardia in SARS-CoV2.

Kumar, Sabina; Arcuri, Christina; Chaudhuri, Sumanta; Gupta, Rahul; Aseri, Mahendra; Barve, Pranav; Shah, Shivang

Kumar, Sabina; Arcuri, Christina; Chaudhuri, Sumanta; Gupta, Rahul; Aseri, Mahendra; Barve, Pranav; Shah, Shivang.

Kumar S; Department of Internal Medicine, Hemet Global Medical Center, Hemet, California, USA.
Arcuri C; Department of Internal Medicine, Hemet Global Medical Center, Hemet, California, USA.
Chaudhuri S; Department of Internal Medicine, Hemet Global Medical Center, Hemet, California, USA.
Gupta R; Department of Internal Medicine, Hemet Global Medical Center, Hemet, California, USA.
Aseri M; Department of Internal Medicine, Hemet Global Medical Center, Hemet, California, USA.
Barve P; Department of Internal Medicine, Hemet Global Medical Center, Hemet, California, USA.
Shah S; Division of Cardiology, Loma Linda University School of Medicine, Loma Linda, California, USA.

Clin Cardiol ; 44(9): 1190-1191, 2021 09.

Article in English | MEDLINE | ID: covidwho-1330311

Subject(s)

COVID-19 Drug Treatment; RNA, Viral; Adenosine Monophosphate/analogs & derivatives; Alanine/analogs & derivatives; Bradycardia/chemically induced; Bradycardia/diagnosis; Humans; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: RNA, Viral / COVID-19 Drug Treatment Type of study: Diagnostic study Limits: Humans Language: English Journal: Clin Cardiol Year: 2021 Document Type: Article Affiliation country: Clc.23700

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google